A See and Treat Paradigm for Cervical Pre-cancer
| Status: | Recruiting |
|---|---|
| Healthy: | No |
| Age Range: | 25 - Any |
| Updated: | 6/7/2018 |
| Start Date: | September 2015 |
| End Date: | August 2020 |
| Contact: | Marlee S Krieger, M.S |
| Email: | marlee.krieger@duke.edu |
| Phone: | 919-660-8446 |
The purpose of this study is to see if the transvaginal colposcope produces similar results
to colposcopy for the screening of cervical cancer. In this study the investigators are using
an investigational device called the transvaginal colposcope. The word investigational means
that the device is still being tested in research studies and is not approved by the U.S.
Food and Drug Administration (FDA).
to colposcopy for the screening of cervical cancer. In this study the investigators are using
an investigational device called the transvaginal colposcope. The word investigational means
that the device is still being tested in research studies and is not approved by the U.S.
Food and Drug Administration (FDA).
Inclusion Criteria:
- Patients undergoing cervicography OR colposcopy OR VIA OR patients undergoing LEEP for
the treatment of cervical cancer.
- Age 25 and greater
- Patients of all ethnic backgrounds will be included.
- Ability to understand and the willingness to sign a written informed consent document.
Exclusion Criteria:
- Children and subjects under 25.
We found this trial at
2
sites
2301 Erwin Rd
Durham, North Carolina 27710
Durham, North Carolina 27710
919-684-8111
Principal Investigator: Nimmi Ramanujam, Ph.D.
Phone: 919-660-5307
Duke Univ Med Ctr As a world-class academic and health care system, Duke Medicine strives...
Click here to add this to my saved trials
Click here to add this to my saved trials